Bulletin of Semashko National Research Institute of Public HealthBulletin of Semashko National Research Institute of Public Health2415-84102415-8429FSSBI «N.A. Semashko National Research Institute of Public Health»280910.69541/NRIPH.2024.04.013Научная статьяComorbidity of multiple sclerosis in womenYakushinMikhail A.yakushinma@mail.ruYakushinDenis M.darthdenis@yandex.ruhttps://orcid.org/0000-0001-9540-1859ShtangInga O.shtanginga@yandex.ruhttps://orcid.org/0000-0003-0355-9443KostrovAlexey A.kostrovich@yandex.ruhttps://orcid.org/0000-0001-7566-212XPershinAndrey V.pershin-7@mail.ruhttps://orcid.org/0009-0004-2247-3244VorobevaAnna V.vorobievaanna2010@yandex.ruhttps://orcid.org/0000-0003-4609-5343YakushinaTatyana I.yakutanya@mail.ruN. A. Semashko National Research Institute of Public HealthMoscow State Regional UniversityResearch Institute for Healthcare Organization and Medical Management of Moscow Healthcare DepartmentMoscow Regional Research and Clinical Institute («MONIKI»)271120244879207052025Copyright © 2025,2025<p>The article analyzes the patterns of the influence of multiple sclerosis on the formation of comorbid pathology, as well as the reverse effect of conjugate pathology on the course of multiple sclerosis. Based on a comprehensive examination of patients with multiple sclerosis in various periods of pregnancy, childbirth and the postpartum period, some patterns of somatic, reproductive health and fertility were revealed. The risk factors for mother and fetus during pregnancy and childbirth, as well as for newborn and mother in the postpartum period, are systematized.</p>comorbiditymultiple sclerosispregnancyreproductive healthfertilityкоморбидностьрассеянный склерозбеременностьрепродуктивное здоровьефертильность1.Lazebnik L.B., Konev Yu.V., Efremov L.I. Quantitative and qualitative assessment of comorbidity in geriatric practice. Experimental and clinical gastroenterology. [Eksperimental'naya i klinicheskaya gastroenterologiya]. 2013;(9):3—8 (in Russian).2.3.Kul'mametov R.R., Pimenov A.A., Rakhmatulloeva Sh.T., NovikovaN.V. Polymorbidity in patients requiring cataract surgery. University medicine of the Urals. [Universitetskaya meditsina Urala]. 2017;3(1):35—36 (in Russian).4.5.Yakushin M.A., Vasil'ev M.D., Bakirova E.A. i dr. Organizational solutions for the analysis of senile comorbidity. Bulletin of the N.A. Semashko National Research Institute of Public Health. [Byulleten' Natsional'nogo nauchno-issledovatel'skogo instituta chestvennogo zdorov'ya imeni N.A.Semashko]. 2023;(3):114—122 (in Russian).6.7.Uspenskiy Yu.P.. Petrenko Yu.V., Gulunov Z.Kh. i dr. Metabolic syndrome. A study guide. — St. Petersburg.; 2017 (in Russian).8.9.Minagar A., Jy W., Jimenez J.J., Alexander J.S. Multiple sclerosis as a vascular disease. J Neurol. Res. 2006;28(3):230—235.10.11.Sternberg Z., Leung C., Sternberg D. et al. The prevalence of the classical and non-classical cardiovascular risk factors in multiple sclerosis patients. J CNS Neurol. Disord. Drug Targets. 2013;12(1):104—111.12.13.Jadidi E., Mohammadi M., Moradi T. High risk of cardiovascular diseases after diagnosis of multiple sclerosis. J Mult. Scler. 2013;19(10):1336—1340.14.15.Marrie R., Horwitz R., Cutter G. et al. Comorbidity, socioeconomic status and multiple sclerosis. J Mult. Scler. 2008;14(8):1091—1098.16.17.Marrie R.A., Patten S.B., Tremlett H. et al. Sex differencesin comorbidity at diagnosis of multiple sclerosis: A population-based study. J Neurology. 2016;86(14):1279—1286.18.19.Marrie R.A., Fisk J., Tremlett H. et al. Differing trends in the incidence of vascular comorbidity in MS and the general population. J Neurol. Clin. Pract. 2016;6(2):120—128.20.21.Barcellos L.F., Kamdar B.B., Ramsay P.P. et al. Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study. J Lancet Neurol. 2006;5(11):924—931.22.23.Laroni A., Calabrese M., Perini P. et al. Multiple sclerosis and autoimmune diseases: epidemiology and HLADR association in North-east Italy. J Neurol. 2006;253(5):636—639.24.25.Kang J.H., Chen Y.H., Lin H.C. Comorbidities amongst patients with multiple sclerosis: a population-based controlled study. J Neurol. 2010;17(9):1215—1219.26.27.Pinhas-Hamiel O., Livne M., Harari G., Achiron A. Prevalence of overweight, obesity and metabolic syndrome components in multiple sclerosis patients with significant disability. J Neurol. 2015;22(9):1275—1279.28.29.Slawta J.N., Wilcox A.R., McCubbin J.A. et al. Health behaviors, body composition, and coronary heart disease risk in women with multiple sclerosis. J Arch. Phys. Med. Rehabil. 2003;84:1823—1830.30.31.Kalron A. Relationship of Obesity With Gait and Balance in People With Multiple Sclerosis. J Phys. Med. Rehabil. 2017;96(3):140—145.32.33.Roshanisefat H., Bahmanyar S., Hillert J. et al. Multiple sclerosis clinical course and cardiovascular disease risk?— Swedish cohort study. J Neurol. 2014;21(11):1353—1388.34.35.Jadidi E., Mohammadi M., Moradi T. High risk of cardiovascular diseases after diagnosis of multiple sclerosis. J Mult. Scler. 2013;19(10):1336—1340.36.37.Christiansen C.F., Christensen S., Farkas D.K. et al. Risk of arterial cardiovascular diseases in patients with multiple sclerosis: a population-based cohortstudy. J Neuroepidemiology. 2010;35(4):267—274.38.39.Allen N.B., Lichtman J.H., Cohen H.W. et al. Vascular disease among hospitalized multiple sclerosis patients. J Neuroepidemiology. 2008;30(4):234—238.40.41.Konukoglu D., Uzun H. Endothelial Dysfunction and Hypertension. J Adv Exp Med Biol. 2017;956:511—540.42.43.Marrie R.A., Rudick R., Horwitz R. et al. Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. J Neurology. 2010;74(13):1041—1047.44.45.Palavra F., Marado D., Mascarenhas-Melo F. et al. New markers of early cardiovascularrisk inmultiple sclerosis patients: oxidized-LDLcorrelates with clinicalstaging. J Dis. Markers. 2013;34(5): 341—348.46.47.Tettey P., Simpson S. Jr., Taylor B. et al. An adverse lipid profile is associated with disability and progression in disability, in people with MS. J Mult. Scler. 2014;20(13):1737—1744.48.49.Weinstock-Guttman B., Zivadinov R., Mahfooz N. et al. Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis. J Neuroinflammation.?2011;8:127.50.51.Conway D.S., Thompson N.R., Cohen J.A. Influence of hypertension, diabetes, hyperlipidemia, and obstructive lung disease on multiple sclerosis disease course. J Mult. Scler. 2017;23(2):277—285.52.53.Neofidov N., Totolyan N., Shumilina M. et al. Arterial hypertension in patients with multiple sclerosis as a significant risk factor of disability progression. J ECTRIMS Online Library. 2018;10:228257.54.55.Horstman L. L, Jy W., Ahn Y. S et al. Role of platelets in neuroinflammation: a wide-angle perspective. J Neuroinflammation. 2010;7:10.56.57.Farez M. F., Correale J. Immunologic effects ofmeformin and pioglitazone treatment onmetabolic syndrome and mulVple sclerosis. J JAMA Neurol. 2016;73:520—528.58.59.Grigolashvili M.A., Rayymbekov A.R., Abylbekov S.M.i dr. Multiple sclerosis in pregnant women. Neurosurgery and neurology of Kazakhstan. [Rasseyannyy skleroz u beremennykh. Neyrokhirurgiya i nevrologiya Kazakhstana]. 2019;1(54):45—51 (in Russian).60.61.Jesus-Ribeiro J., Correia I., Martins A.I., Fonseca M., etc. Pregnancy in Multiple Sclerosis: A Portuguese cohort study. J Mult Scler Relat Disord. 2017;17:63—68.62.63.Finkelsztejn A., Brooks J.B., Paschoal F.M. Jr., Fragoso Y.D. What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature. J BJOG. 2011;118(7):790—797.64.65.Muravin A.I., Boyko A.N., Popova E.V. i dr. The effect of pregnancy on the course of multiple sclerosis. Medical advice. [Meditsinskiy sovet]. 2015;7:23—27 (in Russian).66.67.Pastò L., Portaccio E., Ghezzi A., Hakiki B., Giannini M., etc. Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study. MS Study Group of the Italian Neurological Society. J BMC Neurol. 2012;12:165.68.69.Confavreux C., Hutchinson M., Hours M.M., Cortinovis-Tourniaire P., Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. J N Engl J Med. 1998;339(5):285—291.70.71.Kicherova O.A., Reykhart L.I., Bychenko S.M. Multiple sclerosis. Tyumen: City Press; 2007 (in Russian).72.73.Dwosh E., Guimond C., Sadovnick A. Reproductive counselling for MS: a rationale. J Int. MS. 2003;10:52—59.74.75.MacDonald S.C., McElrath T.F., Hernández-Díaz S. Pregnancy Outcomes in Women With Multiple Sclerosis. J Am J Epidemiol. 2019;188(1):57—66.76.77.Kos'minin D.D., Kos'minina I.A., Gridnev M.A., Logacheva E.A. Multiple sclerosis in pregnant women. In the collection: I Interregional scientific and practical conference «Extragenital pathology and pregnancy». 2017;43—45 (in Russian).78.79.Karnaukh V.N., Barabash I.A. Is pregnancy a risk factor for multiple sclerosis? Influence on the forecast. Far Eastern Medical Journal. [Dal'nevostochnyy meditsinskiy zhurnal]. 2010;(1):131—134 (in Russian).